Position in CGON
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$113,324
+$26,153 QoQ
Shares Held
1,595
+23.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#177
of 226 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. CGON ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in CGON
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,324 | 1,595 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $87,171 | 1,288 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $30,268 | 729 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $29,122 | 723 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $19,474 | 749 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,224 | 50 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,978 | 69 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,565 | 68 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,452 | 46 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $219 | 5 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||